INDIANAPOLIS (WISH) – Here’s a look at Thursday’s business headlines.
Bloomberg reports U.S. drug-safety inspectors have found continuing quality-control problems at a New Jersey Eli Lilly and Co. plant.
The plant is producing its COVID-19 antibody therapy, posing a potential obstacle to the company meeting its goal of producing 1 million doses by year-end.
FDA inspectors found that in some cases, Lilly employees didn’t investigate quality problems and routinely overrode testing systems, according to the documents.
New jobless claims likely remained stubbornly high again last week.
At 870,000, new jobless claims are expected to come in below 1 million for an eighth straight week.
Meanwhile, continuing claims, which measure the number of individuals still receiving state unemployment insurance benefits, are expected to fall back below 10 million for the first time since late March.
New data reveals that people are handling the shift to virtual events with ease. In fact, 90% of people are experiencing increased engagement with virtual gatherings.
Zensar, a digital solutions company, says users like networking virtually, 70% said training and skills development is the leading reason to attend virtually.
Eighty-five million jobs are at risk globally due to automation.
The World Economic Forum reports that could happen within five years.
Jobs set to be increasingly redundant include administrative assistants, bookkeepers and payroll clerks, while positions in growing demand include those in the green economy.
Roles at the forefront of data and artificial intelligence, as well as jobs in engineering, cloud computing and product development.